Effects of once-yearly zoledronic acid on bone density and incident vertebral fractures in nonmetastatic castration-sensitive prostate cancer patients with osteoporosis

BACKGROUND: Androgen deprivation therapy (ADT) is the effective treating prostate cancer but is often accompanied by cancer treatment-induced bone loss (CTIBL), which impairs the patient’s quality of life. In patients with nonmetastatic castration-sensitive prostate cancer (M0CSPC) who already have...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Daisuke, Kimura, Takahiro, Watanabe, Ken, Takano, Hiromitsu, Uehara, Yuko, Minowa, Tadaaki, Yamashita, Akemi, Yoshikawa, Seiichiro, Mizushima, Akio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052675/
https://www.ncbi.nlm.nih.gov/pubmed/33863312
http://dx.doi.org/10.1186/s12885-021-08177-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052675/
https://www.ncbi.nlm.nih.gov/pubmed/33863312
http://dx.doi.org/10.1186/s12885-021-08177-w

Ejemplares similares